investigator_user
investigator
user
funding
collaborators
pending
menu
bell
message
arrow_up
arrow_down
filter
layers
globe
marker
add
arrow
close
download
edit
facebook
info
linkedin
minus
plus
save
share
search
sort
twitter
remove
user-plus
user-minus
Sign Up for Updates
Map
Countries
Cancer types
All cancers but non-melanoma skin cancer
Bladder
Brain, nervous system
Breast
Cervix uteri
Colorectum
Corpus uteri
Gallbladder
Hodgkin lymphoma
Kaposi sarcoma
Kidney, renal pelvis and ureter
Larynx
Leukaemia
Lip, oral cavity
Liver and intrahepatic bile ducts
Melanoma of skin
Multiple myeloma and immunoproliferative diseases
Nasopharynx
Non-Hodgkin lymphoma
Non-Melanoma skin cancer
Oesophagus
Other pharynx
Ovary
Pancreas
Prostate
Sarcoma
Stomach
Testis
Thymus
Thyroid
Trachea, bronchus and lung
Specialities
Hematology and hematologic malignancies
Palliative Care
Pathology
Pediatric oncology or childhood cancer
Radiation Oncology
Surgery / Surgical oncology
Blog
About
Login
Project leads
Collaborators
AP 1. Biodiversity
Gary Rosenberg
0 Collaborator(s)
Funding source
Fogarty International Center (NIH)
Follow
+ Project
+ Post
+ Event
Info
People
Posts
Gary Rosenberg
Oregon Health & Science University
Portland, United States
Related projects
Yves A Declerck
Plasminogen Activator Inhibitor-1 in Tumor Progression and Metastasis
Brain, nervous system
Alec Kimmelman
Investigating the Role of Autophagy in Pancreatic Cancer Radiation Resistance
Pancreas
Radiation Oncology
Bulent Ozpolat
Targeting Kras in Pancreatic Cancer
Pancreas
Anirban Maitra
Imaging and Molecular Correlates of Progression in Cystic Neoplasms of the Pancreas
Pancreas
Michael Gottesman
Genetic Analysis of the Multidrug Resistance Phenotype in Tumor Cells
Brain, nervous system
Susan Bates
Clinical Studies to Circumvent Drug Resistance
Brain, nervous system
Angabin Matin
Use of DND1 to counteract miRNA function in cancers
Pancreas
Stacey Kathryn Ogden
Mechanisms of Hedgehog Ligand Release and Dispersion
Brain, nervous system
Robert M Straubinger
Tumor priming sequences combined with novel nanoparticle drug carriers for enhanced therapeutic efficacy in pancreatic cancer: a tripartite USA/Northern Ireland/Republic of Ireland consortium
Pancreas
Pathology